ASO Author Reflections: Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Gastric Cancer
- PMID: 30324477
- DOI: 10.1245/s10434-018-6919-2
ASO Author Reflections: Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Gastric Cancer
Comment on
-
Efficacy of Adjuvant S-1 Versus XELOX Chemotherapy for Patients with Gastric Cancer After D2 Lymph Node Dissection: A Retrospective, Multi-Center Observational Study.Ann Surg Oncol. 2018 May;25(5):1176-1183. doi: 10.1245/s10434-018-6375-z. Epub 2018 Feb 15. Ann Surg Oncol. 2018. PMID: 29450755
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources